| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |